Literature DB >> 26849625

Beneficial Effects of Norepinephrine Alone on Cardiovascular Function and Tissue Oxygenation in a Pig Model of Cardiogenic Shock.

Alexandra Beurton1, Nicolas Ducrocq, Thomas Auchet, Frédérique Joineau-Groubatch, Aude Falanga, Antoine Kimmoun, Nicolas Girerd, Renaud Fay, Fabrice Vanhuyse, Nguyen Tran, Bruno Levy.   

Abstract

INTRODUCTION: The present study was developed to investigate the effects of norepinephrine alone on hemodynamics and intrinsic cardiac function in a pig model of cardiogenic shock mimicking the clinical setting.
METHODS: Cardiogenic shock was induced by 1-h ligation of the left anterior descending (LAD) artery followed by reperfusion. Pigs were monitored with a Swan-Ganz catheter, a transpulmonary thermodilution catheter, and a conductance catheter placed in the left ventricle for pressure-loop measurements. Measurements were performed before LAD occlusion, 1 h after LAD occlusion, and 4 h after myocardial reperfusion.
RESULTS: Myocardial infarction and reperfusion was followed by cardiogenic shock characterized by a significant increase in heart rate and significant decreases in mean arterial pressure (MAP), mixed venous oxygen saturation (SVO2), left ventricular end-diastolic pressure (LVEDP), prerecruitable stroke work (PRSW), and cardiac power index (CPI). Lactate levels were significantly increased. The systemic vascular resistance index (SVRI) and global end-diastolic volume index (GEDVI) remained unchanged. When compared with the control group (n = 6), norepinephrine infusion (n = 6) was associated with no changes in heart rate, a significant increase in MAP, SVO2, left ventricular ejection fraction, pressure development during isovolumic contraction, SVRI, and CPI and a decrease in lactate level. Cardiac index tended to increase (P = 0.059), whereas PRSW did not change in the norepinephrine group. LVEDP and GEDVI remained unchanged.
CONCLUSIONS: Norepinephrine alone is able to improve hemodynamics, cardiac function, and tissue oxygenation in a pig model of ischemic cardiogenic shock.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26849625     DOI: 10.1097/SHK.0000000000000579

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Clostridium perfringens sepsis complicated by right ventricular cardiogenic shock.

Authors:  Cosmin Balan; Graham Barker; David Garry
Journal:  J Intensive Care Soc       Date:  2016-12-19

2.  Hemodynamics and vasopressor support during targeted temperature management after cardiac arrest with non-shockable rhythm: A post hoc analysis of a randomized controlled trial.

Authors:  Matthieu Petit; Jean-Baptiste Lascarrou; Gwenhael Colin; Hamid Merdji; Alain Cariou; Guillaume Geri
Journal:  Resusc Plus       Date:  2022-07-12

3.  Intra-Arrest Administration of Cyclosporine and Methylprednisolone Does Not Reduce Postarrest Myocardial Dysfunction.

Authors:  Meshe Chonde; Katharyn L Flickinger; Matthew L Sundermann; Allison C Koller; David D Salcido; Cameron Dezfulian; James J Menegazzi; Jonathan Elmer
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

4.  Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs.

Authors:  Clément Delmas; Jean Porterie; Géraldine Jourdan; Frank Lezoualc'h; Romain Arnaud; Stéphanie Brun; Hugo Cavalerie; Grégoire Blanc; Bertrand Marcheix; Olivier Lairez; Patrick Verwaerde; Jeanne Mialet-Perez
Journal:  Front Cardiovasc Med       Date:  2022-02-08

5.  Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.

Authors:  Bruno Garcia; Fuhong Su; Laurence Dewachter; Raphaël Favory; Amina Khaldi; Alexander Moiroux-Sahraoui; Filippo Annoni; Francisco Vasques-Nóvoa; Estela Rocha-Oliveira; Roberto Roncon-Albuquerque; Geraldine Hubesch; Hassane Njimi; Jean-Louis Vincent; Fabio S Taccone; Jacques Creteur; Antoine Herpain
Journal:  Crit Care       Date:  2022-09-18       Impact factor: 19.334

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.